ADENOSINE A2A RECEPTOR-SELECTIVE STIMULATION REDUCES SIGNALING PATHWAYS INVOLVED IN THE DEVELOPMENT OF INTESTINE ISCHEMIA AND REPERFUSION INJURY
- 1 May 2010
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Shock
- Vol. 33 (5), 541-551
- https://doi.org/10.1097/shk.0b013e3181c997dd
Abstract
In the present study, we tested the efficacy of treatment with the selective adenosine A2A receptor agonist 2-[p-(2-carboxyethyl)phenylethylamino]-50-ethylcarboxamidoadenosine (CGS 21680) on ischemia and reperfusion injury of the multivisceral organs. Ischemia and reperfusion injury was induced in mice by clamping both the superior mesenteric artery and the celiac artery for 30 min, followed thereafter by reperfusion. Sixty minutes after reperfusion, animals were killed for histological examination and biochemical studies. Injured vehicle-treated mice developed a significant increase of ileum TNF-α levels, myeloperoxidase activity, and marked histological injury and apoptosis. Ischemia and reperfusion injury of the multivisceral organs was also associated with significant mortality. Reperfused ileum sections from injured vehicle-treated mice showed positive staining for P-selectin and intercellular adhesion molecule 1. The intensity and degree of P-selectin and intercellular adhesion molecule 1 were markedly reduced in tissue sections from injured CGS 21680-treated mice. Ischemia and reperfusion-injured mice that have been treated with CGS 21680 showed also a significant reduction of neutrophil infiltration into the intestine, a reduction of apoptosis, and improved histological status of the intestine and survival. Taken together, our results clearly demonstrate that selective activation of adenosine A2A receptors plays an important role in the regulation of ischemia and reperfusion injury and results put forward the hypothesis that selective activation of adenosine A2A receptors may represent a novel and possible strategy.Keywords
This publication has 30 references indexed in Scilit:
- Comparison of Systemic and Retrograde Delivery of Adenosine A2A Agonist for Attenuation of Spinal Cord Injury After Thoracic Aortic Cross-ClampingThe Annals of Thoracic Surgery, 2006
- Activation of adenosine receptors inhibits tumor necrosis factor-α release by decreasing TNF-α mRNA stability and p38 activityEuropean Journal of Pharmacology, 2004
- PhysiologicalControl ofImmuneResponse andInflammatoryTissueDamage byHypoxia-InducibleFactors andAdenosineA2AReceptorsAnnual Review of Immunology, 2004
- Protection from ischemic liver injury by activation of A2Aadenosine receptors during reperfusion: inhibition of chemokine inductionAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- Adenosine: an endogenous regulator of innate immunityTrends in Immunology, 2004
- The Effect of Intestinal Ischemia and Reperfusion Injury on ICAM-1 Expression, Endothelial Barrier Function, Neutrophil Tissue Influx, and Protease Inhibitor Levels in RatsShock, 2002
- Adenosine A2A analogue ATL-146e reduces systemic tumor necrosing factor-α and spinal cord capillary platelet-endothelial cell adhesion molecule-1 expression after spinal cord ischemiaJournal of Vascular Surgery, 2002
- Adenosine A 2A Receptor Stimulation Reduces Inflammation and Neointimal Growth in a Murine Carotid Ligation ModelArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Beneficial effects of 3‐aminobenzamide, an inhibitor of poly (ADP‐ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusionBritish Journal of Pharmacology, 1997
- ACUTE MESENTERIC ISCHEMIASurgical Clinics of North America, 1997